FindTrial
Sign In

A study to compare and evauate the analgesic effect of amitriptyline and pregabalin in acute phase of herpes zoster

A comparative study to evaluate the analgesic effect of amitriptyline and pregabalin in acute phase of herpes zoster

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014475
Enrollment
90
Registered
2018-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with active herpes zoster

Interventions

Intervention1: Amitriptyline: It is a tricyclic antidepressant with independant analgesic effect in low dose. An oral tablet of 25 mg in night will be given for 12 weeks. Intervention2: Pregabalin: I

Sponsors

Department of anaesthesiology and critical care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: participants in acute phase of herpes zoster

Exclusion criteria

Exclusion criteria: participants with chronic illness on treatment

Design outcomes

Primary

MeasureTime frame
VAS ScoreTimepoint: 0, 2, 4, 6, 8, 10, 12 and 14 weeks—

Secondary

MeasureTime frame
patient satisficationTimepoint: 14 weeks—

Countries

India

Contacts

Public ContactDr Mohit Saini

Pt.B.D.Sharma, PGIMS, Rohtak

para3007@rediffmail.com8222897449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026